Heinrich A, et al. (2021). Central demyelination of the corpus callosum: MRI features and clinical significance. Journal of Neurology, 268(4):1423-1435.
[2]
Kumar A, et al. (2020). Marchiafava-Bignami disease: A comprehensive review. Neurology India, 68(2):345-352.
[3]
Wender M. (2019). Demyelinating diseases of the central nervous system. Neurologia i Neurochirurgia Polska, 53(1):1-12.
[4]
Filippi M, et al. (2022). Multiple sclerosis and related disorders: A review of the evidence. The Lancet Neurology, 21(9):849-864.
[5]
Lennon VA, et al. (2021). Aquaporin-4 autoimmunity and other inflammatory demyelinating diseases of the central nervous system. Seminars in Neurology, 41(3):264-279.
[6]
Sechi G, et al. (2020). Thiamine deficiency and its neurological manifestations: A review. Nutrition Reviews, 78(11):908-921.
[7]
Gupta M, et al. (2021). Neuroimaging of corpus callosum lesions. Neuroimaging Clinics of North America, 31(4):523-540.
[8]
Wali B, et al. (2022). Reversible splenial lesion syndrome: A systematic review. Journal of Clinical Medicine, 11(8):2156.